Basic Information
|
Product Name |
Trelagliptin succinate |
|
Synonyms |
2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile;SYR472 succinate;Zafatek. |
|
CAS |
1029877-94-8 |
|
MF |
C22H26FN5O6 |
|
MW |
475.47000 |
Physical and chemical properties
|
Melting point |
No Information |
|
Storage temp. |
Treasury ventilation, low temperature and dry |
|
Form |
Solid |
|
Color |
White to beige solid |
Mesalamine Usage
|
Uses |
For the treatment of type 2 diabetes |
Drug advantage: It is an ultra-long-acting dipeptidyl peptidase IV (DPP-4) inhibitor by selectively and continuously inhibiting DPP-4 to control blood sugar levels. Traxagliptin is the world's first oral hypoglycemic drug once a week, and similar DPP-4 inhibitors on the market need to be taken orally once a day. The advantages of medication will undoubtedly provide more convenient treatment options for diabetic patients. Significantly improve the convenience and compliance of patients.
Hot Tags: trelagliptin succinate cas no.1029877-94-8, China, manufacturers, suppliers, factory, custom, wholesale, CAS NO 15307 79 6, CAS NO 100306 34 1, Atazanavir Intermediates, CAS NO 383 63 1, CAS NO 685 63 2, Deflazacort Intermediates
